Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Bullboard (TSX:LABS)

View:
Post by okgonowon Jan 22, 2024 11:07am

wow

big bid at $.07 what up???
Comment by subaru1ion Jan 22, 2024 10:52am

RE:RE:RE:Will cannabionid based pharmaceuticals help this? It's not

Your recognition of the threat is correct but your focal point is not.  You have to first realize that like a tiny virus requiring an electron microscope to be able to see it by a human, both ...more  
Comment by okgonowon Jan 22, 2024 8:13am

RE:RE:Will cannabionid based pharmaceuticals help this? It's not

ya sure some other virus to subjugate the masses "for everyones own safety we must take everything from you, your right to travel, your right to own,your right to use the money you earned the way ...more  
Comment by subaru1ion Jan 21, 2024 8:37pm

RE:Will cannabionid based pharmaceuticals help this? It's not

Scientists warn of Arctic 'zombie viruses' with potential to trigger new pandemic Story by Sinead Butler  •  7h https://www.msn.com/en-ca/health/other/scientists-warn-of ...more  
Post by 2busy2on Jan 20, 2024 8:24pm

JUST THINK HOW MUCH IT COST U TO BE AN

EDUCATED  IDIOT  ---OOOOOOOOOOOOOOOOOHOOOHOOHO
Post by 2busy2on Jan 20, 2024 8:14pm

a SUBARU - I have had 1 cold/flu - In 46 yrs. drink

BEER  AND  GREEN  TEA  DAILY -  AUNT  AT 103  THERE  EXPERIMENTING  ON  IN  MICH.  DRINKS   3  LITE  BUSCH  BEERS ...more  
Post by subaru1ion Jan 20, 2024 2:12pm

Will cannabionid based pharmaceuticals help this? It's not

a theory nor is it hypothetical, it is very real because those melting glaciers and massive ice sheets at the poles of the Planet π, as so discovered, for example, over 30 viruses found in an ice core ...more  
Post by 2busy2on Jan 19, 2024 8:38pm

Subaru 1 need BLOZF

to  keep  him  off  the  road  !!!!!!!!!
Post by 2busy2on Jan 19, 2024 1:15pm

.51c-that must mean its going to (trips).0051 cents

I  have  never   seen  a brokerage  prediction   come  true -  YET  
Comment by subaru1ion Jan 19, 2024 1:08pm

RE:RE:Morningstar has a current book value of 0.51c

That's what happens when you machines gathering data and spitting out the statistics because machines, as in computers cannot read and understand the science and the dynamics of clinical trials ...more  
Comment by Redwine12345on Jan 19, 2024 12:12pm

RE:Morningstar has a current book value of 0.51c

Actually it is current price/book value 0.51 per morningstar. This means that the price is twofold below the book value. It is nice to know that company has book value of 13.7 cents/share.  As ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities